These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 39281077)

  • 1. Clinical characteristics and severity markers in hospitalized COVID-19 patients from western Mexico: a comparative analysis of Delta and Omicron variants.
    Ceja-Gálvez HR; Hernández-Ramírez CO; Vega-Magaña AN; Hernández-Bello J; Arellano-Arteaga KJ; Turrubiates-Hernández FJ; Padilla-Borquez DL; Muñoz-Valle JF
    Front Public Health; 2024; 12():1425372. PubMed ID: 39281077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of symptoms, comorbidities, and reinfections in individuals infected with Wild-Type SARS-CoV-2, Delta, or Omicron variants: a comparative study in western Mexico.
    Peña Rodríguez M; Hernández Bello J; Vega Magaña N; Viera Segura O; García Chagollán M; Ceja Gálvez HR; Mora Mora JC; Rentería Flores FI; García González OP; Muñoz Valle JF
    Front Public Health; 2023; 11():1149795. PubMed ID: 37181688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers.
    Ali AM; Tofiq AM; Rostam HM; Ali KM; Tawfeeq HM
    J Med Virol; 2022 Dec; 94(12):5867-5876. PubMed ID: 36029103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Clinical Severity of COVID-19 Variants of Concern: Retrospective Population-Based Analysis.
    Harrigan SP; Velásquez García HA; Abdia Y; Wilton J; Prystajecky N; Tyson J; Fjell C; Hoang L; Kwong JC; Mishra S; Wang L; Sander B; Janjua NZ; Sbihi H
    JMIR Public Health Surveill; 2024 Aug; 10():e45513. PubMed ID: 39190434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.
    Modes ME; Directo MP; Melgar M; Johnson LR; Yang H; Chaudhary P; Bartolini S; Kho N; Noble PW; Isonaka S; Chen P
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):217-223. PubMed ID: 35143466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors for the outcomes of COVID-19 patients infected with SARS-CoV-2 Omicron and Delta variants.
    Gunadi ; Hakim MS; Wibawa H; Vujira KA; Puspitarani DA; Supriyati E; Trisnawati I; Iskandar K; Khair RE; Afiahayati ; Siswanto ; Puspadewi Y; Irianingsih SH; Nugrahaningsih DAA; Eryvinka LS; Utami FDT; Devana EM; Aditama L; Kinasih NCP; Hediningsih Y; Ananda NR; Marcellus ; Arguni E; Nuryastuti T; Wibawa T
    BMC Med Genomics; 2023 Aug; 16(1):205. PubMed ID: 37644458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical characteristics of children with SARS-CoV-2 Omicron variant infection in Kunming].
    Yang JW; Tang CH; Dai M; Duan J; Li YH; Yang J; Yang T; Gao Y; Ban D; Zhu JC; Yuan TY; Li Y; Fu HM
    Zhonghua Er Ke Za Zhi; 2023 Oct; 61(10):922-927. PubMed ID: 37803860
    [No Abstract]   [Full Text] [Related]  

  • 8. [Analyze the clinical characteristics of mild and severe SARS-CoV-2 infected patients based on the local Omicron variant epidemic].
    Yan Y; Lyu C; Davgadorj C; Wang X; Sha M
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Jan; 35(1):32-36. PubMed ID: 36880235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study.
    Lauring AS; Tenforde MW; Chappell JD; Gaglani M; Ginde AA; McNeal T; Ghamande S; Douin DJ; Talbot HK; Casey JD; Mohr NM; Zepeski A; Shapiro NI; Gibbs KW; Files DC; Hager DN; Shehu A; Prekker ME; Erickson HL; Exline MC; Gong MN; Mohamed A; Johnson NJ; Srinivasan V; Steingrub JS; Peltan ID; Brown SM; Martin ET; Monto AS; Khan A; Hough CL; Busse LW; Ten Lohuis CC; Duggal A; Wilson JG; Gordon AJ; Qadir N; Chang SY; Mallow C; Rivas C; Babcock HM; Kwon JH; Halasa N; Grijalva CG; Rice TW; Stubblefield WB; Baughman A; Womack KN; Rhoads JP; Lindsell CJ; Hart KW; Zhu Y; Adams K; Schrag SJ; Olson SM; Kobayashi M; Verani JR; Patel MM; Self WH;
    BMJ; 2022 Mar; 376():e069761. PubMed ID: 35264324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory Biomarkers Differ among Hospitalized Veterans Infected with Alpha, Delta, and Omicron SARS-CoV-2 Variants.
    Park C; Tavakoli-Tabasi S; Sharafkhaneh A; Seligman BJ; Hicken B; Amos CI; Chou A; Razjouyan J
    Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36833680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of SARS-Cov-2 omicron variant with the previously identified SARS-Cov-2 variants in Egypt, 2020-2022: insight into SARS-Cov-2 genome evolution and its impact on epidemiology, clinical picture, disease severity, and mortality.
    Kandeel A; Moatasim Y; Fahim M; Bahaaeldin H; El-Shesheny R; Roshdy WH; Kamel MN; Shawky S; Gomaa M; Naguib A; Guindy NE; Deghedy O; Kamel R; Khalifa M; Galal R; Hassany M; Mahmoud G; Kandeil A; Afifi S; Mohsen A; Fattah MA; Kayali G; Ali MA; Abdelghaffar K
    BMC Infect Dis; 2023 Aug; 23(1):542. PubMed ID: 37596534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Portable Breath-Based Volatile Organic Compound Monitoring for the Detection of COVID-19 During the Circulation of the SARS-CoV-2 Delta Variant and the Transition to the SARS-CoV-2 Omicron Variant.
    Sharma R; Zang W; Tabartehfarahani A; Lam A; Huang X; Sivakumar AD; Thota C; Yang S; Dickson RP; Sjoding MW; Bisco E; Mahmood CC; Diaz KM; Sautter N; Ansari S; Ward KR; Fan X
    JAMA Netw Open; 2023 Feb; 6(2):e230982. PubMed ID: 36853606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of SARS-CoV-2 variants of concern over a period of Delta and Omicron cocirculation, among patients hospitalized for COVID-19 in an Italian reference hospital: Impact on clinical outcomes.
    Mondi A; Mastrorosa I; Piselli P; Cimaglia C; Matusali G; Carletti F; Giannico G; Milozzi E; Biliotti E; Di Bari S; Chinello P; Beccacece A; Faraglia F; Vittozzi P; Mosti S; Tetaj N; Stazi GV; Pinnetti C; Camici M; D'Annunzio A; Marani A; Fabeni L; Specchiarello E; Gruber CEM; Villanacci A; Minicucci S; Garbuglia AR; Ianniello S; Marchioni L; Taglietti F; D'Offizi G; Palmieri F; Nicastri E; Maggi F; Vaia F; Girardi E; Antinori A
    J Med Virol; 2023 Jun; 95(6):e28831. PubMed ID: 37246793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MIS-C across three SARS-CoV-2 variants: Changes in COVID-19 testing and clinical characteristics in a cohort of U.S. children.
    Laird-Gion J; Dionne A; Gauvreau K; Baker A; Day-Lewis M; de Ferranti S; Friedman K; Khan N; Mahanta S; Son MB; Sperotto F; Newburger JW
    Eur J Pediatr; 2023 Jun; 182(6):2865-2872. PubMed ID: 37055630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transmissibility, hospitalization, and intensive care admissions due to omicron compared to delta variants of SARS-CoV-2 in Catalonia: A cohort study and ecological analysis.
    Català M; Coma E; Alonso S; Andrés C; Blanco I; Antón A; Bordoy AE; Cardona PJ; Fina F; Martró E; Medina M; Mora N; Saludes V; Prats C; Prieto-Alhambra D; Alvarez-Lacalle E
    Front Public Health; 2022; 10():961030. PubMed ID: 36033822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 Disease Severity and Cycle Threshold Values in Children Infected during Pre-Delta, Delta, and Omicron Periods, Colorado, USA, 2021-2022.
    Bankers L; O'Brien SC; Tapay DM; Ho E; Armistead I; Burakoff A; Dominguez SR; Matzinger SR
    Emerg Infect Dis; 2024 Jun; 30(6):1182-1192. PubMed ID: 38781929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.
    Gram MA; Emborg HD; Schelde AB; Friis NU; Nielsen KF; Moustsen-Helms IR; Legarth R; Lam JUH; Chaine M; Malik AZ; Rasmussen M; Fonager J; Sieber RN; Stegger M; Ethelberg S; Valentiner-Branth P; Hansen CH
    PLoS Med; 2022 Sep; 19(9):e1003992. PubMed ID: 36048766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Patients Infected With Delta Versus Omicron COVID-19 Variants Presenting to Paris Emergency Departments : A Retrospective Cohort Study.
    Bouzid D; Visseaux B; Kassasseya C; Daoud A; Fémy F; Hermand C; Truchot J; Beaune S; Javaud N; Peyrony O; Chauvin A; Vaittinada Ayar P; Bourg A; Riou B; Marot S; Bloom B; Cachanado M; Simon T; Freund Y;
    Ann Intern Med; 2022 Jun; 175(6):831-837. PubMed ID: 35286147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Quick Displacement of the SARS-CoV-2 variant Delta with Omicron: Unprecedented Spike in COVID-19 Cases Associated with Fewer Admissions and Comparable Upper Respiratory Viral Loads.
    Fall A; Eldesouki RE; Sachithanandham J; Morris CP; Norton JM; Gaston DC; Forman M; Abdullah O; Gallagher N; Li M; Swanson NJ; Pekosz A; Klein EY; Mostafa HH
    medRxiv; 2022 Jan; ():. PubMed ID: 35118480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological factors associated with long COVID and comparative analysis of SARS-CoV-2 spike protein variants: a retrospective study in Thailand.
    Kiatratdasakul S; Noisumdaeng P; Niyomdecha N
    PeerJ; 2024; 12():e17898. PubMed ID: 39175748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.